Hologic to highlight its breast continuum of care

At Hologic, we are dedicated to providing innovative technologies focused on women’s health, helping healthcare professionals diagnose and treat their patients with precision, certainty and confidence. Our technology underpins the majority of breast cancer and cervical cancer screening programmes in the UK, and sexually transmitted infection testing as well as gynaecological and other surgical services for women.

What’s more is that our innovations have real-world impact. With over 30 years of experience, our innovations are designed to achieve exceptional clinical outcomes, making it possible to detect, diagnose and treat illnesses and other health conditions earlier and more effectively. At Hologic, we know that artificial intelligence (AI)-powered technology is fundamental in advancing innovation in healthcare. Widespread adoption of this innovation will drive significant diagnostic accuracy, improvement in patient care and experience, and, in parallel, will deliver important potential savings to healthcare systems. Hologic is proud to be leading the way.

Shaping the future of breast health care, from screening to excellence in disease management, to prioritising women’s health and wellbeing for the most enriched life, to innovation, is core to what we do at Hologic. We call it the Breast Health Continuum of Care.

For more information about Hologic’s breast continuum of care, please visit: hologic.co.uk/en-gb/breast-health.

Visit Medica at BIRAC25 on stand 15.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated BIR AI conference page to find out more.